IL22 and hypersensitivity pneumonitis: The pathological scores of alveolitis at day 7 (p = 0.011, Figure 4D) and fibrosis at day 21 (p = 0.007, Figure 4E) were significantly decreased in mice treated with both BLM and IL‐22 (n = 6) as compared with BLM mice (n = 6).